shopping cart
nothing in cart
 
browse by subject
new releases
best sellers
sale books
browse by author
browse by publisher
home
about us
upcoming events
Aug 14th - Deep Summer Retreat [Hugh Smiley]
Sep 4th - The Deepest Kindness: ACT and the Therapeutic Relationship [Ottawa River Psychology Group]
Sep 14th - Integrating EMDR into Your Clinical Practice: Five-Day Intensive in Toronto [Leading Edge Seminars]
Sep 23rd - Supporting the Mental Health Needs of Racialized Young People [SickKids CCMH Learning Institute]
Sep 24th - OAMHP 2020 Conference - Diversity in Action: Mental Health for the Underserved [OAMHP - Ontario Association of Mental Health Professionals]
schools agencies and other institutional orders (click here)
Free shipping across Canada for all orders over $50. Please read our Covid-19 statement here.
Join our mailing list! Click here to sign up.
Pharmacotherapies for the Treatment of Opioid Dependence : Efficiency, Cost-Effectiveness and Implementation Guidelines
Mattick, Richard P., Robert Ali and Nicholas Lintzeris
CRC Press / Informa Healthcare / Softcover / 2009-03-01 / 1841844004
Psychopharmacology / Addiction
reg price: $136.95 our price: $ 123.26 (may be subject to change)
288 pages
Not in Stock, usually ships in 7-10 business days

The most comprehensive text of its kind, this book addresses both the management of opioid withdrawal and opioid maintenance therapy, and combines up-to-date reviews of the scientific literature with evidence-based clinical guidelines for all of the relevant pharmacotherapies.
A unique work, Pharmacotherapies for the Treatment of Opioid Dependence presents:

* detailed information on the cost-effectiveness of the various types of opioid treatment
* the range of pharmacotherapies used for the management of opioid dependence
* the state of knowledge from the international research literature on the value and relative efficacy of the various pharmacological approaches.

This includes pharmacotherapies used in the management of withdrawal from opioids such as clonidine, lofexidine, methadone, buprenorphine and naltrexone and also symptomatic medications. It also includes different forms of maintenance therapy using opioid agonists such as methadone, LAAM, buprenorphine, slow-release oral morphine and diamorphine, and opioid antagonists such as naltrexone.

This text should appeal to researchers, to identify gaps in the research literature and provide a basis for determining appropriate research directionspolicy makers, to clinicians by providing clinical with clinical guidelines and information concerning the empirical basis for the treatments, and to policy makers in assisting them to make decisions about the various treatments from a public health perspective, taking into account the relative cost and effectiveness of the interventions.

--- from the publisher

Contents:

Section One: Introduction

1. Extent of Opioid Dependence and Management to Date

2. Pharmacology of Opioid Agonists and Antagonists

Section Two: Outcomes for Withdrawal

3. Management of Heroin Withdrawal

Section Three: Outcomes for Maintenance Treatment

4. Methadone Maintenance Treatment

5. LAAM Maintenance Treatment

6. Buprenorphine Maintenance Treatment

7. Other Forms of Opioid Agonist Maintenance Treatment

8. Naltrexone Maintenance/abstinence Orientated Therapy

Section Four: Outcomes from the National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD) Project

9. Methodology of the NEPOD Project

10. The Relative Effectiveness of Withdrawal and Maintenance Treatments

11. Health Economic Methods and Outcomes

Section Five: Process Issues

12. Pharmacotherapies and Pregnancy

13. Adjuvant Psychosocial Interventions and Rehabilitation

14. Assessing Opioid Dependent Patients and Matching Them to Treatment

15. Models of Service Delivery

Section Six: Implementation Guidelines

16. Clinical Guidelines for Treatment with Methadone

17. Clinical Guidelines for Treatment with Buprenorphine

18. Clinical Guidelines for Treatment with LAAM

19. Clinical Guidelines for Treatment with Naltrexone

Section Seven: Conclusion

20. Future Directions

Author Biography:

Richard P. Mattick is Director of Research, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia. Prof. Mattick is Executive Editor of journal Drug and Alcohol Review and is Assistant Editor of the journal Addiction (previously British Journal of Addiction).

Caversham Booksellers
98 Harbord St, Toronto, ON M5S 1G6 Canada
(click for map and directions)
All prices in $cdn
Copyright 2020

Phone toll-free (800) 361-6120
Tel (416) 944-0962 | Fax (416) 944-0963
E-mail [email protected]
Hours: 9-6 Mon-Sat / Closed Sunday (EST)

search
Click here to read previous issues.
other lists
Addiction
informa healthcare
Martin Dunitz
Psychopharmacology
Taylor and Francis